Search Results - "Cerasa, Laura Serafina"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Effects of early life permethrin exposure on spatial working memory and on monoamine levels in different brain areas of pre-senescent rats by Nasuti, Cinzia, Carloni, Manuel, Fedeli, Donatella, Gabbianelli, Rosita, Di Stefano, Antonio, Laura Serafina, Cerasa, Silva, Isabel, Domingues, Valentina, Ciccocioppo, Roberto

    Published in Toxicology (Amsterdam) (07-01-2013)
    “…Highlights ► Neonatal exposure to permethrin induces cognitive deficits in pre-senescent rats. ► Spatial working memory was tested in a T-maze-rewarded…”
    Get full text
    Journal Article
  2. 2

    L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment by Di Stefano, Antonio, Sozio, Piera, Cerasa, Laura Serafina, Iannitelli, Antonio

    Published in Current pharmaceutical design (01-11-2011)
    “…L-Dopa is the mainstay of Parkinson's disease therapy; this drug is usually administered orally, but it is extensively metabolized in the gastrointestinal…”
    Get more information
    Journal Article
  3. 3

    Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain by Tayebati, Seyed Khosrow, Tomassoni, Daniele, Nwankwo, Innocent Ejike, Di Stefano, Antonio, Sozio, Piera, Cerasa, Laura Serafina, Amenta, Francesco

    Published in CNS & neurological disorders drug targets (01-02-2013)
    “…Choline-containing phospholipids were proposed as cognition enhancing agents, but evidence on their activity is controversial. CDP-choline…”
    Get more information
    Journal Article
  4. 4

    Carvacrol codrugs: a new approach in the antimicrobial plan by Cacciatore, Ivana, Di Giulio, Mara, Fornasari, Erika, Di Stefano, Antonio, Cerasa, Laura Serafina, Marinelli, Lisa, Turkez, Hasan, Di Campli, Emanuela, Di Bartolomeo, Soraya, Robuffo, Iole, Cellini, Luigina

    Published in PloS one (10-04-2015)
    “…The increasing prevalence of antibiotic-resistant bacterial infections led to identify alternative strategies for a novel therapeutic approach. In this study,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Antiparkinson prodrugs by Di Stefano, Antonio, Sozio, Piera, Cerasa, Laura Serafina

    Published in Molecules (16-01-2008)
    “…Parkinson's disease (PD) is a progressive, neurodegenerative disorder which involves the loss of dopaminergic neurons of the substantia nigra pars compacta…”
    Get full text
    Journal Article Book Review
  8. 8

    Effect of choline-containing phospholipids on brain cholinergic transporters in the rat by Tayebati, Seyed Khosrow, Tomassoni, Daniele, Di Stefano, Antonio, Sozio, Piera, Cerasa, Laura Serafina, Amenta, Francesco

    Published in Journal of the neurological sciences (15-03-2011)
    “…Abstract The influence of one week treatment with the choline-containing phospholipids cytidine-5′-diphosphocholine (CDP-choline) and choline alphoscerate…”
    Get full text
    Journal Article
  9. 9

    New drug delivery strategies for improved Parkinson's disease therapy by Di Stefano, Antonio, Sozio, Piera, Iannitelli, Antonio, Cerasa, Laura Serafina

    Published in Expert opinion on drug delivery (01-04-2009)
    “…Increasing interest has been addressed toward the introduction of new therapeutic approaches to obtaining continuous dopaminergic stimulation (CDS). The goal…”
    Get more information
    Journal Article
  10. 10

    Effect of 17β-estradiol on striatal dopaminergic transmission induced by permethrin in early childhood rats by Nasuti, Cinzia, Carloni, Manuel, Fedeli, Donatella, Di Stefano, Antonio, Marinelli, Lisa, Cerasa, Laura Serafina, Meda, Clara, Maggi, Adriana, Gabbianelli, Rosita

    Published in Chemosphere (Oxford) (01-10-2014)
    “…•Early life permethrin treated leads to dopaminergic alterations.•Decrease of dopamine was observed in rats co-administered with PERM+17β-estradiol.•Permethrin…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Designing prodrugs for the treatment of Parkinson's disease by Sozio, Piera, Cerasa, Laura Serafina, Abbadessa, Anna, Di Stefano, Antonio

    Published in Expert opinion on drug discovery (01-05-2012)
    “…Current Parkinson's disease (PD) therapy is essentially symptomatic, and l-Dopa (LD), is the treatment of choice in more advanced stages of the disease…”
    Get more information
    Journal Article
  14. 14
  15. 15

    New L-Dopa Codrugs as Potential Antiparkinson Agents by Sozio, Piera, Iannitelli, Antonio, Cerasa, Laura Serafina, Cacciatore, Ivana, Cornacchia, Catia, Giorgioni, Gianfabio, Ricciutelli, Massimo, Nasuti, Cinzia, Cantalamessa, Franco, Di Stefano, Antonio

    Published in Archiv der Pharmazie (Weinheim) (01-07-2008)
    “…This paper reports the synthesis and preliminary evaluation of new L‐dopa (LD) conjugates (1 and 2) obtained by joining LD with two different natural…”
    Get full text
    Journal Article
  16. 16

    Carvacrol Codrugs: A New Approach in the Antimicrobial Plan: e0120937 by Cacciatore, Ivana, Giulio, Mara Di, nasari, Erika, Stefano, Antonio Di, Cerasa, Laura Serafina, Marinelli, Lisa, Turkez, Hasan, Campli, Emanuela Di, Bartolomeo, Soraya Di, Robuffo, Iole

    Published in PloS one (01-04-2015)
    “…Objective The increasing prevalence of antibiotic-resistant bacterial infections led to identify alternative strategies for a novel therapeutic approach. In…”
    Get full text
    Journal Article